title: Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.
abstract: Chemokines (chemotactic cytokines) are a family of proteins associated with the trafficking and activation of leukocytes and other cell types in immune surveillance and inflammatory response. Besides their roles in the immune system, they play pleiotropic roles in tumor initiation, promotion, and progression. Chemokines can be classified into four subfamilies of chemokines, CXC, CC, C, or CX3C, based on their number and spacing of conserved cysteine residues near the N-terminus. This CXC subfamily can be further subclassified into two groups, depending on the presence or absence of a tripeptide motif glutamic acid-leucine-arginine (ELR) in the N-terminal domain. ELR(-)CXCL12, which binds to CXCR4 has been frequently implicated in various cancers. Over the past several years, studies have increasingly shown that the CXCR4/CXCL12 axis plays critical roles in tumor progression, such as invasion, angiogenesis, survival, homing to metastatic sites. This review focuses on involvement of CXCR4/CXCL12 interaction in neuroectodermal cancers and their therapeutic potentials. As an attractive therapeutic target of CXCR4/CXCL12 axis for cancer chemotherapy, development history and application of CXCR4 antagonists are described.
authors.affiliation: Department of Radiology, Emory University, Atlanta, GA 30322, USA.
authors.forename: Hyunsuk
authors.initials: H
authors.lastname: Shim
authors.forename: Shinya
authors.initials: S
authors.lastname: Oishi
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Fujii
mesh_terms: D000818:Animals; D054377:Chemokine CXCL12 / Q000145:classification / Q000502:physiology*; D006801:Humans; D017599:Neuroectodermal Tumors / Q000378:metabolism* / Q000473:pathology; D019718:Receptors, CXCR4 / Q000145:classification / Q000502:physiology*
chemical_list: D054377:Chemokine CXCL12; D019718:Receptors, CXCR4